How much does a box of genuine lorlatinib cost?

Lorlatinib is an innovative oral tyrosine kinase (ALK) and ROS1 (ROS1< span>kinase) inhibitors, mainly used to treat non-small cell lung cancer (NSCLC) caused by ALK and ROS1 mutations. As a third-generation targeted drug, lorlatinib has shown excellent efficacy in targeting ALK and ROS1 mutations, especially in patients who have developed resistance to previous treatments.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. Please consult the local hospital pharmacy for details. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.

Lorlatinib is designed to overcome drug resistance and has broad inhibitory effects against multiple ALK and ROS1 variants. This broad spectrum makes it an effective tool in treating multiple variants of lung cancer. In addition, lorlatinib also demonstrated relatively good tolerability, providing patients with a more comfortable treatment option.

Its performance in clinical trials has attracted widespread attention. Studies have shown that lorlatinib achieved longer progression survival (Progression-Free Survival, PFS) in some patients and delayed the progression of the disease. Lorlatinib offers a glimmer of hope for patients who have relapsed after other treatments.

In addition, lorlatinib has relatively mild side effects on other organs and has been shown in some clinical studies to maintain a higher quality of life during treatment.